Literature DB >> 8747892

The iron-selective chelator desferal can reduce chelated copper.

D M Van Reyk1, R T Dean.   

Abstract

It was shown that the iron-selective chelator desferal (desferrioxamine mesylate:DFO) can reduce Cu(II) as judged by measuring the formation of the complex between Cu(I) and a specific chelator for this species, neocuproine (NC), in phosphate buffer. It was found that under optimal conditions, 3 moles of Cu(II) could be reduced per mole of DFO. Studies of the kinetics of Cu(II) reduction by DFO revealed that the rate of Cu(II) reduction by DFO was considerably slower than that by ascorbate. In the case of both reductants, even in the absence of NC, Cu(I) complexes remained in aqueous solutions for at least 30 min. DFO could also reduce Cu complexed to histidine. The results presented highlight the interpretive dangers which can arise in studies involving multiple transition metals, especially in the presence of multiple chelators. Specifically, when desferal is used, it is important to be aware that any copper present may become reduced, and that any Cu(I) formed might participate in ongoing redox reactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8747892     DOI: 10.3109/10715769609087999

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  4 in total

1.  Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.

Authors:  M Hermes-Lima; M S Gonçalves; R G Andrade
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

2.  BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases.

Authors:  D G Tang; L Li; Z Zhu; B Joshi; C R Johnson; L J Marnett; K V Honn; J D Crissman; S Krajewski; J C Reed; J Timar; A T Porter
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  Combustion of dried animal dung as biofuel results in the generation of highly redox active fine particulates.

Authors:  Ian S Mudway; Sean T Duggan; Chandra Venkataraman; Gazala Habib; Frank J Kelly; Jonathan Grigg
Journal:  Part Fibre Toxicol       Date:  2005-10-04       Impact factor: 9.400

4.  Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.

Authors:  Szu-Jung Chen; Ching-Chuan Kuo; Hsin-Yi Pan; Tsui-Chun Tsou; Szu-Ching Yeh; Jang-Yang Chang
Journal:  Oncotarget       Date:  2016-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.